An echocardiogram uses ultrasound waves to create images of the heart in motion — reveals heart structure (chambers, walls, valves), function (pumping strength, filling), blood flow, and surrounding tissues. Non-invasive, painless, uses no radiation. Types: transthoracic echocardiogram (TTE — most common, probe on chest), stress echocardiogram (combined with exercise or medication-induced stress), transesophageal echocardiogram (TEE — probe inserted through esophagus for clearer images), Doppler (measures blood flow), 3D echo. For most adults with diabetes, TTE is standard. Procedure: lie on table; ultrasound gel applied; probe moved on chest; 30-60 minutes; immediate or near-immediate results. When adults with diabetes need echocardiogram: symptoms (shortness of breath, leg swelling, fatigue), heart murmur on exam, abnormal EKG findings, suspected heart failure, after heart attack, pre-operative evaluation, monitoring known heart conditions, suspected diabetic cardiomyopathy, pulmonary hypertension assessment. Not routine like EKG. Cost: $1,000-3,000 without insurance; covered with medical necessity. Diabetic cardiomyopathy is heart muscle disease specifically associated with diabetes, independent of coronary artery disease — affects 50-60% of adults with type 2 diabetes (often subclinical). Mechanisms: direct hyperglycemia damage, microvascular disease in heart muscle, lipid abnormalities, insulin resistance effects, inflammation. Manifestations: diastolic dysfunction (heart muscle stiffening — impaired relaxation; commonly impaired in diabetes), left ventricular hypertrophy, eventually systolic dysfunction (reduced pumping), restrictive filling pattern. Risk increases with poor glycemic control and longer diabetes duration. Treatment: tight glucose control, blood pressure management, ACE inhibitors, SGLT2 inhibitors (CV outcomes benefit), beta-blockers, weight loss. Echocardiogram is primary diagnostic tool. What echocardiogram shows: ejection fraction (pumping strength, normal 55-70%), LVH (wall thickness), diastolic function, valve function, wall motion abnormalities (prior heart attack or ischemia), pericardial effusion, right heart function, pulmonary pressures.
Echocardiogram Types
| Type | Description | When Used |
|---|---|---|
| Transthoracic (TTE) | Probe on chest; most common | Standard screening; symptoms |
| Stress echocardiogram | With exercise or medication stress | Suspected ischemia; pre-surgical |
| Transesophageal (TEE) | Probe through esophagus; clearer images | Heart valve assessment; clots |
| Doppler | Measures blood flow direction and speed | Valve regurgitation; stenosis |
| 3D echocardiogram | Three-dimensional imaging | Complex anatomy; surgical planning |
| Fetal echocardiogram | Of developing fetal heart | Prenatal screening; family history |
Diabetic Cardiomyopathy
- Heart muscle disease associated with diabetes; independent of coronary artery disease.
- Affects 50-60% of adults with type 2 diabetes (often subclinical).
- Mechanisms: hyperglycemia direct damage, microvascular disease in heart, lipid abnormalities, insulin resistance, inflammation.
- Stages: diastolic dysfunction → systolic dysfunction → heart failure.
- Diastolic dysfunction = heart muscle stiffening (impaired relaxation).
- Often progresses over years with continued hyperglycemia.
- Risk factors: poor glucose control, longer diabetes duration, hypertension, obesity.
- Treatment: glycemic control, blood pressure management, SGLT2 inhibitors (cardiovascular outcomes benefit), ACE inhibitors, beta-blockers.
- SGLT2 inhibitors (empagliflozin, dapagliflozin) particularly beneficial for heart failure in diabetes.
Echocardiogram Findings
- Ejection fraction: pumping strength; normal 55-70%; reduced in heart failure.
- Left ventricular hypertrophy: thickened wall; suggests hypertension or strain.
- Diastolic dysfunction: impaired relaxation; common in diabetes.
- Wall motion abnormalities: areas not contracting; prior heart attack or ischemia.
- Valve function: stenosis (narrowing) or regurgitation (leaking).
- Pericardial effusion: fluid around heart.
- Pulmonary hypertension: elevated right-sided pressures.
- Atrial enlargement: associated with atrial fibrillation.
- Right ventricular function.
- Septal wall thickness: in symmetric hypertrophy.
Indications for Echocardiogram in Diabetes
- Shortness of breath, especially with activity.
- Leg swelling (edema).
- Unexplained fatigue.
- Heart murmur on physical exam.
- Abnormal EKG findings.
- Suspected heart failure.
- After heart attack — assess damage.
- Pre-operative evaluation.
- Monitoring known heart conditions.
- Suspected diabetic cardiomyopathy.
- New atrial fibrillation.
- Stroke evaluation.
- Long-standing poorly controlled diabetes with hypertension.
What to Expect
- Lie on examination table.
- Ultrasound gel applied to chest.
- Probe (transducer) moved across chest.
- Hold breath occasionally for clearer images.
- 30-60 minutes typically.
- Painless except slight pressure from probe.
- Continue medications.
- Results read by cardiologist.
- Stress echo: additional exercise or medication injection.
- TEE: requires sedation; pre-test fasting; throat numbing.
The Bottom Line
An echocardiogram uses ultrasound waves to create images of the heart in motion — reveals heart structure (chambers, walls, valves), function (pumping strength, filling), blood flow, and surrounding tissues. Non-invasive, painless, uses no radiation. Types: transthoracic echocardiogram (TTE — most common, probe on chest), stress echocardiogram (combined with exercise or medication-induced stress), transesophageal echocardiogram (TEE — probe inserted through esophagus for clearer images), Doppler (measures blood flow), 3D echo. For most adults with diabetes, TTE is standard. Procedure: lie on table; ultrasound gel applied; probe moved on chest; 30-60 minutes; results immediate or near-immediate. Echocardiogram is not routine for diabetes monitoring like EKG can be — ordered when clinical indication exists. Indications: symptoms (shortness of breath, leg swelling, fatigue), heart murmur on exam, abnormal EKG findings, suspected heart failure, after heart attack, pre-operative evaluation, monitoring known heart conditions, suspected diabetic cardiomyopathy, new atrial fibrillation. Cost: $1,000-3,000 without insurance; covered with medical necessity. Diabetic cardiomyopathy is heart muscle disease specifically associated with diabetes, independent of coronary artery disease — affects 50-60% of adults with type 2 diabetes (often subclinical). Mechanisms: hyperglycemia direct damage, microvascular disease in heart muscle, lipid abnormalities, insulin resistance, inflammation. Progression: diastolic dysfunction (heart muscle stiffening — impaired relaxation; commonly impaired in diabetes) → systolic dysfunction (reduced pumping) → heart failure. Risk increases with poor glycemic control and longer diabetes duration. Treatment: tight glucose control, blood pressure management, SGLT2 inhibitors (empagliflozin, dapagliflozin — heart failure benefit demonstrated in trials), ACE inhibitors, beta-blockers, weight loss. Echocardiogram is primary diagnostic tool. What echocardiogram shows: ejection fraction (pumping strength, normal 55-70%), left ventricular hypertrophy, diastolic function, valve function, wall motion abnormalities (prior heart attack or ischemia), pericardial effusion, right heart function, pulmonary pressures. Process: lie on table, ultrasound gel applied, probe moved across chest, hold breath occasionally, 30-60 minutes typically, painless. Continue medications. Results read by cardiologist. Stress echo adds exercise or medication; TEE requires sedation and pre-test fasting. For adults with type 2 diabetes, echocardiogram is essential when clinical symptoms suggest heart problems or to evaluate diabetic cardiomyopathy. Combined with EKG and other testing, provides comprehensive cardiac assessment. See our broader diabetes heart attack risk guide for context.
